(2014) showed that microglial NF-B is involved in the disease-like phenotypes progression in SOD1-G93A mice and suppression of NF-B reduces proinflammatory microglial activation (Frakes et al., 2014)
Others extend their stash by microdosing, administering sub-clinical doses such as 0.25 to 1mg per week, in a bid to save money
A review of animal models utilized in preclinical studies of approved gene therapy products: trends and insights
When you take a GLP-1 agonist , the appetite suppression can be profound
A provider-guided assessment should precede any GLP-1 therapy, including cardiovascular history, thyroid status, and gastrointestinal tolerance
Michael Baumann is a Global Product Manager for METHOCEL within the Health & Pharma Solutions business group at Roquette